Management of Staphylococcus ureilyticus Infection
Treat Staphylococcus ureilyticus infections as coagulase-negative staphylococcal infections, following established guidelines for catheter-related bloodstream infections (CRBSI) when applicable, with vancomycin as first-line empirical therapy pending susceptibility results.
Clinical Context and Pathogen Classification
Staphylococcus ureilyticus is a coagulase-negative staphylococcus (CoNS) species that remains poorly characterized in clinical literature. Recent genomic analysis reveals it harbors antimicrobial resistance genes and has zoonotic potential 1. Since specific treatment guidelines for S. ureilyticus do not exist, management should follow established protocols for CoNS infections.
Diagnostic Approach
Confirm true infection versus contamination:
- Obtain at least 2 sets of blood cultures from different sites (at least 1 peripheral) 2, 3
- Multiple positive blood cultures from different sites strongly suggest true CRBSI rather than contamination 2
- For catheter-related infections, use quantitative or semiquantitative catheter tip cultures 4
Critical distinction: CoNS are the most common blood culture contaminant AND the most common cause of CRBSI, making interpretation challenging 2.
Antibiotic Selection
Empirical Therapy
Start with vancomycin in hospitals with increased methicillin-resistant staphylococci 4. This covers both methicillin-susceptible and resistant CoNS while awaiting susceptibility results.
Definitive Therapy (after susceptibilities known)
- Methicillin-susceptible strains: Transition to nafcillin, oxacillin, or cefazolin 4
- Methicillin-resistant strains: Continue vancomycin 2, 4
- Alternative agents: Linezolid, daptomycin, or well-absorbed oral agents (clindamycin, doxycycline, fluoroquinolones) for uncomplicated cases 2
Treatment Duration Based on Clinical Scenario
Uncomplicated CRBSI (catheter removed)
5-7 days of antibiotics if:
- Catheter is removed
- No intravascular or orthopedic hardware present
- Blood cultures clear promptly
- No signs of metastatic infection 2
Alternative approach: Observation without antibiotics is acceptable if catheter removed, no hardware present, and repeat blood cultures confirm clearance 2
Uncomplicated CRBSI (catheter retained)
10-14 days of systemic antibiotics PLUS antibiotic lock therapy 2, 3, 2
Antibiotic lock specifications:
- Duration: 7-14 days 3
- Dwell time: ≥12 hours (minimum 8 hours/day), not exceeding 48 hours before reinstallation 3
- Can combine with oral antibiotics for outpatient management 2
Complicated Infections
4-6 weeks of therapy if any of the following present:
- Persistent bacteremia after catheter removal
- Endocarditis (obtain transesophageal echocardiography if suspected)
- Septic thrombophlebitis
- Metastatic infection 2, 4, 3
6-8 weeks for osteomyelitis 3, 4, 3
Source Control Decisions
Mandatory Catheter Removal
Remove catheter immediately if:
- Severe sepsis or hemodynamic instability
- Tunnel infection or port abscess
- Persistent bacteremia despite 48-72 hours of appropriate therapy
- Suppurative thrombophlebitis 3
Catheter Salvage Acceptable
May attempt retention with antibiotic lock therapy if:
- Uncomplicated infection
- No tunnel or exit site infection
- Patient clinically stable
- Long-term catheter with difficult replacement 2, 4, 3
Critical Pitfalls to Avoid
Do not dismiss positive cultures as contaminants without clinical correlation—multiple positive cultures from different sites indicate true infection 2
Antibiotic lock therapy only treats intraluminal infection—it has no effect on extraluminal infection, which predominates in catheters present <2 weeks 2
Do not use vancomycin for methicillin-susceptible isolates once susceptibilities known—beta-lactams are superior 4
Screen for metastatic complications in patients with persistent fever, ongoing bacteremia, or prosthetic devices—CoNS can rarely cause endocarditis and metastatic infections 2
Given the documented antimicrobial resistance potential of S. ureilyticus 1, always obtain susceptibility testing and adjust therapy accordingly
Special Consideration: S. lugdunensis Exception
If the isolate is later identified as Staphylococcus lugdunensis (another CoNS), manage as S. aureus with catheter removal and 4-6 weeks of therapy due to its propensity for endocarditis and metastatic infection 2.